News

Génome Québec and Cystic Fibrosis Canada announce the launch of the Tackle Rare, Orphan CFTR Mutations Competition to support research on rare mutations for which no treatment is available, with the long-term goal of developing novel therapies.

Cystic Fibrosis Canada has opened its annual grant competition for 2024. Canadian researchers with an interest in cystic fibrosis (CF), including its connection to diabetes and cancer, can now apply for funding to be awarded starting in early 2025.

Progress has been made towards improving access to the life-changing cystic fibrosis (CF) medication, Trikafta, in Canada.

CF Canada successfully hosted the virtual CF Canada Community Forum: "Unchartered Territories" on April 26, 2024. If you couldn’t make it to CF Canada’s Community Forum “Unchartered Territories" last week, CF Canada has you covered!

It is with great pleasure that Génome Québec and Cystic Fibrosis Canada join forces to create a new funding program to support omics research on cystic fibrosis.

 The team at Cystic Fibrosis Canada is pleased to share our 2023-24 Impact Report.

Cystic Fibrosis Canada asks participants to take a #StepToward ending cystic fibrosis for all Canadians with cystic fibrosis.

Just in time for cystic fibrosis awareness month, Cystic Fibrosis Canada is excited to be making our podcast debut with today’s launch of Breathless.  

Funding will fuel continued research advancement with goal of reducing complications of cystic fibrosis and identifying therapeutic options for those who currently lack them.

Data from Canadian Cystic Fibrosis Registry 2022 Annual Data Report  suggest that today’s babies with cystic fibrosis could live longer than ever before;  fatal disease requires further action to change prognosis.